Michael Straughen - 01 Apr 2025 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Reporting relationship: Director
Issuer ticker: CLB
Reported as of: 01 Apr 2025
Net transaction value: -$69,417
SEC form: 4
Accepted by SEC: 02 Apr 2025, 14:33:12 UTC
Prior SEC filing: 02 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Mark Tattoli, Attorney-in-Fact

Key filing fact

Michael Straughen filed Form 4 for Core Laboratories Inc. /DE/ (CLB) on 02 Apr 2025.

Key facts

This page summarizes Michael Straughen's Form 4 filing for Core Laboratories Inc. /DE/ (CLB).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Apr 2025, 14:33.

Change

Previous filing in this sequence was filed on 02 Apr 2024.
Current net transaction value: -$69,417.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLB transaction

Common Stock

Tax liability

Transaction value: $69,417
Shares: -4,634
Change %: -16%
Price: $14.98
Shares after: 24,552
Date: 01 Apr 2025
Ownership: Direct

CLB transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +9,317
Change %: +47%
Price: $0.000000
Shares after: 29,186
Date: 01 Apr 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLB transaction Derivative

Restricted Shares

Options Exercise

Transaction value: $0
Shares: -9,317
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Apr 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,317
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .